Core Laboratories (CLB) Total Debt (2022 - 2026)
Core Laboratories filings provide 5 years of Total Debt readings, the most recent being $114.5 million for Q1 2026.
- On a quarterly basis, Total Debt fell 7.97% to $114.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was $114.5 million, a 7.97% decrease, with the full-year FY2025 number at $110.3 million, down 12.57% from a year prior.
- Total Debt hit $114.5 million in Q1 2026 for Core Laboratories, up from $110.3 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $182.6 million in Q2 2023 to a low of $110.3 million in Q4 2025.
- Median Total Debt over the past 5 years was $139.9 million (2024), compared with a mean of $142.9 million.
- Biggest five-year swings in Total Debt: dropped 5.37% in 2023 and later fell 22.69% in 2024.
- Core Laboratories' Total Debt stood at $172.4 million in 2022, then decreased by 5.37% to $163.1 million in 2023, then decreased by 22.69% to $126.1 million in 2024, then fell by 12.57% to $110.3 million in 2025, then rose by 3.81% to $114.5 million in 2026.
- The last three reported values for Total Debt were $114.5 million (Q1 2026), $110.3 million (Q4 2025), and $114.1 million (Q3 2025) per Business Quant data.